Elevance Health EBIT Margin 2010-2025 | ELV
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Elevance Health (ELV) over the last 10 years. The current EBIT profit margin for Elevance Health as of March 31, 2025 is .
| Elevance Health EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-03-31 | $183.33B | $9.03B | 4.92% |
| 2024-12-31 | $177.01B | $9.09B | 5.13% |
| 2024-09-30 | $174.22B | $9.40B | 5.40% |
| 2024-06-30 | $171.96B | $9.64B | 5.61% |
| 2024-03-31 | $171.75B | $9.08B | 5.29% |
| 2023-12-31 | $171.34B | $8.75B | 5.10% |
| 2023-09-30 | $168.62B | $8.76B | 5.19% |
| 2023-06-30 | $165.71B | $9.19B | 5.54% |
| 2023-03-31 | $160.67B | $8.81B | 5.49% |
| 2022-12-31 | $156.60B | $8.45B | 5.40% |
| 2022-09-30 | $153.25B | $8.86B | 5.78% |
| 2022-06-30 | $149.13B | $8.72B | 5.85% |
| 2022-03-31 | $144.35B | $8.95B | 6.20% |
| 2021-12-31 | $138.64B | $8.81B | 6.36% |
| 2021-09-30 | $133.88B | $7.93B | 5.92% |
| 2021-06-30 | $129.22B | $6.35B | 4.92% |
| 2021-03-31 | $124.63B | $7.14B | 5.73% |
| 2020-12-31 | $121.87B | $7.06B | 5.79% |
| 2020-09-30 | $117.45B | $7.55B | 6.42% |
| 2020-06-30 | $112.97B | $8.60B | 7.61% |
| 2020-03-31 | $109.17B | $6.89B | 6.31% |
| 2019-12-31 | $104.21B | $6.73B | 6.46% |
| 2019-09-30 | $100.18B | $6.17B | 6.16% |
| 2019-06-30 | $96.76B | $5.92B | 6.12% |
| 2019-03-31 | $94.23B | $5.98B | 6.35% |
| 2018-12-31 | $92.11B | $5.83B | 6.33% |
| 2018-09-30 | $91.41B | $5.68B | 6.21% |
| 2018-06-30 | $90.59B | $5.52B | 6.09% |
| 2018-03-31 | $90.05B | $5.22B | 5.79% |
| 2017-12-31 | $90.04B | $4.99B | 5.54% |
| 2017-09-30 | $89.07B | $5.25B | 5.90% |
| 2017-06-30 | $88.05B | $5.29B | 6.01% |
| 2017-03-31 | $87.10B | $5.53B | 6.35% |
| 2016-12-31 | $84.86B | $5.28B | 6.22% |
| 2016-09-30 | $83.34B | $4.99B | 5.99% |
| 2016-06-30 | $81.84B | $4.97B | 6.08% |
| 2016-03-31 | $80.40B | $5.05B | 6.28% |
| 2015-12-31 | $79.16B | $5.28B | 6.66% |
| 2015-09-30 | $77.95B | $5.77B | 7.40% |
| 2015-06-30 | $76.61B | $5.79B | 7.56% |
| 2015-03-31 | $75.07B | $5.50B | 7.32% |
| 2014-12-31 | $73.87B | $5.05B | 6.83% |
| 2014-09-30 | $72.79B | $4.62B | 6.35% |
| 2014-06-30 | $72.09B | $4.48B | 6.22% |
| 2014-03-31 | $71.31B | $4.43B | 6.22% |
| 2013-12-31 | $71.02B | $4.59B | 6.46% |
| 2013-09-30 | $68.44B | $4.60B | 6.72% |
| 2013-06-30 | $65.94B | $4.58B | 6.95% |
| 2013-03-31 | $63.66B | $4.39B | 6.89% |
| 2012-12-31 | $61.50B | $4.37B | 7.11% |
| 2012-09-30 | $61.49B | $4.34B | 7.05% |
| 2012-06-30 | $61.54B | $4.33B | 7.03% |
| 2012-03-31 | $61.23B | $4.27B | 6.98% |
| 2011-12-31 | $60.71B | $4.39B | 7.23% |
| 2011-09-30 | $60.02B | $4.66B | 7.77% |
| 2011-06-30 | $59.19B | $4.75B | 8.03% |
| 2011-03-31 | $58.52B | $4.87B | 8.32% |
| 2010-12-31 | $58.70B | $4.77B | 8.13% |
| 2010-09-30 | $63.03B | $8.35B | 13.25% |
| 2010-06-30 | $63.89B | $8.34B | 13.05% |
| 2010-03-31 | $64.87B | $8.28B | 12.76% |
| 2009-12-31 | $64.94B | $7.85B | 12.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $66.101B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.067B | 27.09 |
| CVS Health (CVS) | United States | $78.811B | 9.80 |
| Cencora (COR) | United States | $56.558B | 19.68 |
| DiDi Global (DIDIY) | China | $24.238B | 25.75 |
| Labcorp Holdings (LH) | United States | $22.089B | 17.43 |
| Natera (NTRA) | United States | $19.248B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.897B | 0.00 |
| ICON (ICLR) | Ireland | $14.657B | 14.10 |
| CochLear (CHEOY) | Australia | $13.278B | 0.00 |
| Solventum (SOLV) | United States | $12.626B | 13.37 |
| Medpace Holdings (MEDP) | United States | $12.299B | 32.55 |
| Revvity (RVTY) | United States | $10.708B | 18.58 |
| Viatris (VTRS) | United States | $10.563B | 3.63 |
| Avantor (AVTR) | United States | $9.404B | 13.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.654B | 16.96 |
| HealthEquity (HQY) | United States | $8.544B | 37.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.505B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 32.64 |
| Amplifon S.p.A (AMFPF) | Italy | $3.871B | 21.19 |
| BrightSpring Health Services (BTSG) | United States | $3.746B | 34.37 |
| Sotera Health (SHC) | United States | $3.382B | 19.22 |
| GeneDx Holdings (WGS) | United States | $2.953B | 68.10 |
| Surgery Partners (SGRY) | United States | $2.867B | 37.28 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Alignment Healthcare (ALHC) | United States | $2.572B | 0.00 |
| Progyny (PGNY) | United States | $2.014B | 44.34 |
| Premier (PINC) | United States | $1.772B | 13.45 |
| GoodRx Holdings (GDRX) | United States | $1.747B | 34.93 |
| PACS (PACS) | United States | $1.710B | 0.00 |
| Ardent Health (ARDT) | United States | $1.528B | 6.51 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.065B | 8.10 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| CareDx (CDNA) | United States | $0.716B | 11.18 |
| AMN Healthcare Services Inc (AMN) | United States | $0.712B | 6.67 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| So-Young (SY) | China | $0.501B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.479B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| LifeMD (LFMD) | United States | $0.459B | 0.00 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.455B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.454B | 10.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| Enhabit (EHAB) | United States | $0.338B | 27.83 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |